Ho Carole sold DNLI
August 13, 2025 · Form 4 insider transaction
Ho Carole sold 806 shares of Denali Therapeutics Inc. at $14.64 per share, a transaction worth $11.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
806
Price
$14.64
Total value
$11.8K
InsiderHo Carole
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 14, 2025
Shares owned after216,585
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted December 11, 2024.; Includes 128,405 Unvested RSUs.